AmeriCann (ACAN) AI Stock Analysis

• Market Cap: $2.44K
• Dividend Yield: N/A
• Average Volume (3M): 63.76K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.61
• Revenue Growth: -65.15%
• EPS Growth: -720.17%
• Country: US
• Employees: 3
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Services
• EPS (TTM): -0.10
• Shares Outstanding: 24,391,960
• 10 Day Avg. Volume: 71,517
• 30 Day Avg. Volume: 63,758
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 4.33K
• Enterprise Value/Revenue: 12.85
• Enterprise Value/Gross Profit: 12.89
• Enterprise Value/Ebitda: -7.34
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 47 Neutral
• Price Target: ―

AmeriCann's overall stock score is primarily driven by its financial performance challenges, with declining revenues, high leverage, and negative cash flows posing significant risks. Despite some positive technical indicators suggesting short-term strength, the stock's valuation remains concerning due to ongoing losses and no dividend yield. This combination of factors results in a low overall stock score, reflecting caution for potential investors.

AmeriCann Business Overview & Revenue Model

Company Description

AmeriCann, Inc. operates as a specialized cannabis company in the United States. It designs, develops, leases, and operates cultivation, processing, and manufacturing facilities for licensed cannabis businesses. The company's flagship project is the Massachusetts Cannabis Center that is developed on a 52-acre parcel of land located in Freetown, southeastern Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is based in Denver, Colorado.

How the Company Makes Money

AmeriCann makes money primarily through leasing its cannabis cultivation and processing facilities to licensed operators. The company invests in the development of large-scale, efficient cannabis production facilities and enters into agreements with cannabis businesses to lease these spaces. Revenue is generated from rental income, which may be based on fixed lease payments, variable rent based on the tenant's sales performance, or a combination of both. Additionally, AmeriCann may form strategic partnerships with cannabis operators, potentially offering consulting services and facility management solutions to enhance tenant operations and maximize facility productivity.

AmeriCann Financial Statement Overview

Summary

AmeriCann faces significant financial challenges, including declining revenues, high leverage, and negative cash flows. The company needs to address its operational inefficiencies and manage its debt levels to improve financial health. Stability and profitability are currently weak, posing risks to future growth and sustainability.

Income Statement

The company shows a declining revenue trend with significant negative net income, indicating profitability challenges. Gross profit margin is high, but negative EBIT and EBITDA margins in the recent year reflect operational inefficiencies. The revenue growth rate is negative, showing a concerning trend.

Balance Sheet

The debt-to-equity ratio is high, indicating potential leverage risk. Stockholders' equity has decreased, weakening financial stability. The equity ratio is low, suggesting a higher proportion of assets financed by liabilities, which may pose a risk.

Cash Flow

The company has negative operating and free cash flows, indicating cash flow management issues. The free cash flow has significantly decreased, and operating cash flow to net income ratio is negative, reflecting operational cash flow challenges.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	1.27M	2.55M	2.93M	2.03M	503.51K
Gross Profit	1.27M	2.54M	2.88M	1.99M	481.01K
EBITDA	-172.00K	1.14M	1.01M	580.74K	660.86K
Net Income	-1.25M	-94.75K	-173.00K	-863.00K	-709.00K
Balance Sheet
Total Assets	14.06M	15.15M	15.44M	15.06M	14.87M
Cash, Cash Equivalents and Short-Term Investments	48.84K	1.14M	1.34M	696.38K	183.01K
Total Debt	9.29M	9.30M	9.30M	9.20M	8.56M
Total Liabilities	9.61M	9.45M	9.64M	9.55M	8.99M
Stockholders Equity	4.45M	5.71M	5.80M	5.51M	5.87M
Cash Flow
Free Cash Flow	-1.17M	300.69K	603.16K	-368.55K	131.85K
Operating Cash Flow	-1.17M	579.86K	848.74K	-275.15K	518.33K
Investing Cash Flow	83.90K	-635.98K	-204.01K	-58.64K	-357.24K
Financing Cash Flow	0.00	-150.00K	0.00	847.00K	-1.26M

AmeriCann Technical Analysis

• Last Price: 0.02

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACAN, the sentiment is undefined. The current price of 0.02 is equal to the 20-day moving average (MA) of ―, equal to the 50-day MA of ―, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a undefined sentiment for ACAN.

AmeriCann Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IIPR	69 Neutral	$1.54B	11.89	7.30%	14.18%	-7.80%	-18.78%
CRON	69 Neutral	C$1.58B	56.78	1.71%	―	31.72%	―
SMG	52 Neutral	$3.22B	72.72	-31.07%	4.64%	-2.05%	―
GRWG	52 Neutral	$124.92M	-2.27	-45.88%	―	-20.55%	-2.43%
TLRY	50 Neutral	$2.05B	-0.75	-198.52%	―	4.10%	-594.06%
ACAN	47 Neutral	$2.44K	―	-54.80%	―	-65.15%	-720.17%
Sector *	65 Neutral	$2.17B	12.19	3.79%	4.94%	3.15%	1.96%